Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Nasopharyngeal carcinoma
Epidemiological trends during the past decade suggest that although incidence of
nasopharyngeal carcinoma is gradually declining, even in endemic regions, mortality from …
nasopharyngeal carcinoma is gradually declining, even in endemic regions, mortality from …
Head and neck cancers
Head and Neck Cancers in: Journal of the National Comprehensive Cancer Network Volume
9 Issue 6 (2011) Jump to Content User Account Sign In to save searches and organize your …
9 Issue 6 (2011) Jump to Content User Account Sign In to save searches and organize your …
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin as first-line therapy for recurrent or metastatic nasopharyngeal carcinoma: final overall survival analysis of …
PURPOSE GEM20110714 (ClinicalTrials. gov identifier: NCT01528618), the first
randomized, phase III study of systemic chemotherapy in recurrent or metastatic …
randomized, phase III study of systemic chemotherapy in recurrent or metastatic …
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal …
Background The effect of the addition of adjuvant chemotherapy to concurrent
chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma is unclear. We …
chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma is unclear. We …
Randomized trial of radiotherapy versus concurrent chemoradiotherapy followed by adjuvant chemotherapy in patients with American Joint Committee on Cancer …
Purpose The Intergroup 00-99 Trial for nasopharyngeal cancer (NPC) showed a benefit of
adding chemotherapy to radiotherapy. However, there were controversies regarding the …
adding chemotherapy to radiotherapy. However, there were controversies regarding the …
Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinoma
The outcomes for patients with metastatic or locally recurrent Epstein–Barr virus (EBV)-
positive nasopharyngeal carcinoma (NPC) remain poor. Adoptive immunotherapy with EBV …
positive nasopharyngeal carcinoma (NPC) remain poor. Adoptive immunotherapy with EBV …
Concurrent chemo-radiation with or without induction gemcitabine, carboplatin, and paclitaxel: a randomized, phase 2/3 trial in locally advanced nasopharyngeal …
Purpose To compare survival, tumor control, toxicities, and quality of life of patients with
locally advanced nasopharyngeal carcinoma (NPC) treated with induction chemotherapy …
locally advanced nasopharyngeal carcinoma (NPC) treated with induction chemotherapy …
Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis
Background MicroRNAs (miRNAs) can be used as prognostic biomarkers in many types of
cancer. We aimed to identify miRNAs that were prognostic in patients with nasopharyngeal …
cancer. We aimed to identify miRNAs that were prognostic in patients with nasopharyngeal …
The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
Y Hou, Q Zhu, Z Li, Y Peng, X Yu, B Yuan, Y Liu… - Cell death & …, 2017 - nature.com
Paclitaxel is clinically used as a first-line chemotherapeutic regimen for several cancer
types, including head and neck cancers. However, acquired drug resistance results in the …
types, including head and neck cancers. However, acquired drug resistance results in the …
[HTML][HTML] A phase II study evaluating the safety and efficacy of an adenovirus-ΔLMP1-LMP2 transduced dendritic cell vaccine in patients with advanced metastatic …
ABSTRACT Background Individuals with metastatic Epstein–Barr virus (EBV)-positive
nasopharyngeal carcinoma (NPC) continue to have poor outcomes. To evaluate the ability …
nasopharyngeal carcinoma (NPC) continue to have poor outcomes. To evaluate the ability …